Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-COVID-19 Pulmonary Fibrosis.
Mohammadi A, Balan I, Yadav S, Matos WF, Kharawala A, Gaddam M, Sarabia N, Koneru SC, Suddapalli SK, Marzban S. Mohammadi A, et al. Among authors: matos wf. Cureus. 2022 Mar 2;14(3):e22770. doi: 10.7759/cureus.22770. eCollection 2022 Mar. Cureus. 2022. PMID: 35371880 Free PMC article. Review.
Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension.
Mohammadi A, Matos WF, Intriago C, Thakkar K, Jahan N, Shah H, Nishu RI, Marzban S. Mohammadi A, et al. Among authors: matos wf. Cureus. 2021 Sep 22;13(9):e18191. doi: 10.7759/cureus.18191. eCollection 2021 Sep. Cureus. 2021. PMID: 34707962 Free PMC article. Review.
Thymosin alpha 1: A comprehensive review of the literature.
Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Fahem MMM, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Dominari A, et al. World J Virol. 2020 Dec 15;9(5):67-78. doi: 10.5501/wjv.v9.i5.67. World J Virol. 2020. PMID: 33362999 Free PMC article. Review.
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Q, Mease PJ, Chiorean M, Iles-Shih L, Matos WF, Baumgartner A, Molani S, Hwang YM, Belhu B, Ralevski A, Hadlock J. Wei Q, et al. Among authors: matos wf. Lancet Digit Health. 2024 May;6(5):e309-e322. doi: 10.1016/S2589-7500(24)00021-9. Lancet Digit Health. 2024. PMID: 38670740 Free PMC article.
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system.
Wei Q, Mease PJ, Chiorean M, Iles-Shih L, Matos WF, Baumgartner A, Molani S, Hwang YM, Belhu B, Ralevski A, Hadlock J. Wei Q, et al. Among authors: matos wf. medRxiv [Preprint]. 2023 Jun 28:2023.06.26.23291904. doi: 10.1101/2023.06.26.23291904. medRxiv. 2023. Update in: Lancet Digit Health. 2024 May;6(5):e309-e322. doi: 10.1016/S2589-7500(24)00021-9 PMID: 37425752 Free PMC article. Updated. Preprint.
Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping.
Duvvuri VR, Baumgartner A, Molani S, Hernandez PV, Yuan D, Roper RT, Matos WF, Robinson M, Su Y, Subramanian N, Goldman JD, Heath JR, Hadlock JJ. Duvvuri VR, et al. Among authors: matos wf. Health Data Sci. 2022;2022:0002. doi: 10.34133/hds.0002. Epub 2022 Dec 27. Health Data Sci. 2022. PMID: 36817759 Free PMC article.